- Home
- KNSA vs BUSE Comparison
KNSA vs BUSE Comparison
Compare KNSA & BUSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- BUSE
- Stock Information
- Founded
- KNSA 2015
- BUSE 1868
- Country
- KNSA United Kingdom
- BUSE United States
- Employees
- KNSA N/A
- BUSE N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- BUSE Major Banks
- Sector
- KNSA Health Care
- BUSE Finance
- Exchange
- KNSA Nasdaq
- BUSE Nasdaq
- Market Cap
- KNSA 1.9B
- BUSE 1.9B
- IPO Year
- KNSA 2018
- BUSE N/A
- Fundamental
- Price
- KNSA $27.36
- BUSE $22.12
- Analyst Decision
- KNSA Strong Buy
- BUSE Buy
- Analyst Count
- KNSA 5
- BUSE 5
- Target Price
- KNSA $38.80
- BUSE $27.80
- AVG Volume (30 Days)
- KNSA 474.9K
- BUSE 433.4K
- Earning Date
- KNSA 07-22-2025
- BUSE 07-22-2025
- Dividend Yield
- KNSA N/A
- BUSE 4.52%
- EPS Growth
- KNSA N/A
- BUSE N/A
- EPS
- KNSA N/A
- BUSE 0.95
- Revenue
- KNSA $481,166,000.00
- BUSE $430,476,000.00
- Revenue This Year
- KNSA $37.21
- BUSE $62.50
- Revenue Next Year
- KNSA $5.32
- BUSE $12.41
- P/E Ratio
- KNSA N/A
- BUSE $23.16
- Revenue Growth
- KNSA 59.45
- BUSE 0.48
- 52 Week Low
- KNSA $17.38
- BUSE $18.40
- 52 Week High
- KNSA $28.56
- BUSE $28.97
- Technical
- Relative Strength Index (RSI)
- KNSA 62.48
- BUSE 54.10
- Support Level
- KNSA $26.28
- BUSE $21.41
- Resistance Level
- KNSA $27.90
- BUSE $22.31
- Average True Range (ATR)
- KNSA 0.99
- BUSE 0.40
- MACD
- KNSA -0.07
- BUSE -0.04
- Stochastic Oscillator
- KNSA 82.30
- BUSE 46.41
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About BUSE First Busey Corporation
First Busey Corporation is a financial holding company, whose subsidiaries provides retail and commercial banking services, remittance processing, and offers financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech and Wealth Management. The banking segment generates a vast majority of its revenue.